Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-24 Sale | 2026-02-26 8:12 pm | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 75,000 | $12.01 | $900,788 | 2,850,821 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 8:05 pm | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 25,000 | $10 | $250,000 | 67,937 (Direct) | View |
| 2026-02-20 Sale | 2026-02-24 8:03 pm | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 175,000 | $10.19 | $1,783,602 | 2,941,066 (Direct) | View |
| 2026-01-20 Sale | 2026-01-21 8:34 pm | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 151,967 | $7.2009 | $1,094,297 | 3,091,604 (Direct) | View |
| 2026-01-16 Sale | 2026-01-21 8:33 pm | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 75,000 | $5.8353 | $437,650 | 210,874 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-23 Exercise | 2026-02-24 8:05 pm | N/A 2032-06-14 | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 25,000 | $0 | 67,937 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 25,000 | $2.98 | 67,937 (Direct) | View |
| 2026-02-22 Exercise | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 40,650 | $0 | 340,794 (Direct) | View |
| 2026-02-22 Tax Withholding | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 20,682 | $8.7 | 340,794 (Direct) | View |
| 2026-02-22 Exercise | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC Cambridge Equities LP MP 13 Ventures LLC Nant Capital LLC See remarks 10% Owner | 114,329 | $0 | 650,120,069 (Direct) | View |
| 2026-02-22 Tax Withholding | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC Cambridge Equities LP MP 13 Ventures LLC Nant Capital LLC See remarks 10% Owner | 58,170 | $8.7 | 650,120,069 (Direct) | View |
| 2026-02-22 Exercise | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 4,065 | $0 | 119,940 (Direct) | View |
| 2026-02-22 Tax Withholding | 2026-02-24 8:05 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 1,673 | $8.7 | 119,940 (Direct) | View |
| 2026-02-22 Exercise | 2026-02-24 8:04 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 152,439 | $0 | 712,783 (Direct) | View |
| 2026-02-22 Tax Withholding | 2026-02-24 8:04 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 77,560 | $8.7 | 712,783 (Direct) | View |
| 2026-02-22 Exercise | 2026-02-24 8:03 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 15,243 | $0 | 2,941,066 (Direct) | View |
| 2026-02-22 Tax Withholding | 2026-02-24 8:03 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 6,026 | $8.7 | 2,941,066 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-12 9:29 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC Cambridge Equities LP MP 13 Ventures LLC Nant Capital LLC See remarks 10% Owner | 274,122 | $0 | 650,497,827 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 9:29 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC Cambridge Equities LP MP 13 Ventures LLC Nant Capital LLC See remarks 10% Owner | 118,560 | $6.93 | 650,497,827 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-12 8:50 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 82,236 | $0 | 444,649 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 8:50 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 42,643 | $6.93 | 444,649 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-12 8:50 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 5,482 | $0 | 124,448 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 8:50 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 2,257 | $6.93 | 124,448 (Direct) | View |
| 2026-02-10 Exercise | 2026-02-12 8:50 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 274,122 | $0 | 1,033,711 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 8:50 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 140,048 | $6.93 | 1,033,711 (Direct) | View |
| 2026-01-16 Exercise | 2026-01-21 8:33 pm | N/A 2032-06-14 | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 75,000 | $0 | 210,874 (Direct) | View |
| 2026-01-16 Exercise | 2026-01-21 8:33 pm | N/A N/A | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 75,000 | $2.98 | 210,874 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 6:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 15,435 | $1.98 | 286,184 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 6:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 30,397 | $0 | 286,184 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 6:10 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 17,510 | $1.98 | 403,122 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 6:10 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 34,483 | $0 | 403,122 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-16 5:55 pm | N/A 2035-12-12 | ImmunityBio Inc. | IBRX | Wendel Bruce Director | 146,020 | $0 | 146,020 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 6:34 pm | N/A 2035-06-18 | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 162,786 | $0 | 162,786 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 6:34 pm | N/A 2035-06-18 | ImmunityBio Inc. | IBRX | Cohen Cheryl Director | 162,786 | $0 | 162,786 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 6:34 pm | N/A 2035-06-18 | ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director | 162,786 | $0 | 162,786 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 6:34 pm | N/A 2035-06-18 | ImmunityBio Inc. | IBRX | MAXWELL LINDA Director | 162,786 | $0 | 162,786 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 6:34 pm | N/A 2035-06-18 | ImmunityBio Inc. | IBRX | Clark Wesley Director | 162,786 | $0 | 162,786 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 1,669 | $3.42 | 118,388 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 4,065 | $0 | 118,388 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 42,071 | $3.42 | 650,022,677 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 114,329 | $0 | 650,022,677 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 15,860 | $3.42 | 306,921 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 40,650 | $0 | 306,921 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 78,167 | $3.42 | 639,296 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 152,439 | $0 | 639,296 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 5,453 | $3.42 | 3,274,059 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 9:11 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 15,243 | $0 | 3,274,059 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 8:17 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK See remarks 10% Owner | 3,634,868 | $0 | 3,634,868 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 8:16 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 72,697 | $0 | 72,697 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 8:16 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 1,090,460 | $0 | 1,090,460 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 8:16 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 3,634,868 | $0 | 3,634,868 (Direct) | View |
| 2025-01-22 Exercise | 2025-01-24 8:47 pm | N/A 2025-02-16 | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 110,020 | $0 | 3,233,781 (Direct) | View |
| 2025-01-22 Exercise | 2025-01-24 8:47 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 110,020 | $1.9984 | 3,233,781 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 4:54 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 17,475 | $2.56 | 346,360 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 4:54 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 34,483 | $0 | 346,360 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-03 4:54 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 15,405 | $2.56 | 276,829 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-03 4:54 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 30,397 | $0 | 276,829 (Direct) | View |
| 2024-12-15 Exercise | 2024-12-16 7:36 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 21,031 | $0 | 107,862 (Direct) | View |
| 2024-12-15 Tax Withholding | 2024-12-16 7:36 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 7,503 | $2.87 | 107,862 (Direct) | View |
| 2024-12-10 Other | 2024-12-12 9:20 pm | 2024-12-10 2027-12-31 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 505,000,000 | $505,000,000 | 1,154,721,761 (Indirect) | View |
| 2024-12-10 Conversion | 2024-12-12 9:20 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 103,710,088 | $1.935 | 1,154,721,761 (Indirect) | View |
| 2024-12-10 Other | 2024-12-12 9:20 pm | 2023-12-29 2025-12-31 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 380,000,000 | $0 | 1,154,721,761 (Indirect) | View |
| 2024-12-10 Conversion | 2024-12-12 9:20 pm | N/A 2026-09-11 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 230,000,000 | $0 | 1,154,721,761 (Indirect) | View |
| 2024-12-10 Conversion | 2024-12-12 9:20 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner | 13,475,172 | $2.28 | 1,154,721,761 (Indirect) | View |
| 2024-06-11 Option Award | 2024-06-13 6:50 pm | N/A 2034-06-11 | ImmunityBio Inc. | IBRX | Brennan John Owen Director | 77,633 | $0 | 77,633 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 6:49 pm | N/A 2034-06-11 | ImmunityBio Inc. | IBRX | Clark Wesley Director | 77,633 | $0 | 77,633 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 6:49 pm | N/A 2034-06-11 | ImmunityBio Inc. | IBRX | Cohen Cheryl Director | 77,633 | $0 | 77,633 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 6:49 pm | N/A 2034-06-11 | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 77,633 | $0 | 77,633 (Direct) | View |